Exact Mass: 354.1678
Exact Mass Matches: 354.1678
Found 500 metabolites which its exact mass value is equals to given mass value 354.1678
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tephrowatsin A
A hydroxyflavan that is (2S)-flavan substituted by hydroxy group at position 4, methoxy groups at positions 5 and 7 and a prenyl group at position 8 respectively.
Sultopride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Same as: D08549
3,6-Dimethoxyestra-1,3,5(10),6,8-pentaene-17beta-carboxylic acid methyl ester
Valganciclovir
Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
Isopropyl apiosylglucoside
Isopropyl apiosylglucoside is found in root vegetables. Isopropyl apiosylglucoside is a constituent of the roots of cassava (Manihot esculenta). Constituent of the roots of cassava (Manihot esculenta). Isopropyl apiosylglucoside is found in root vegetables.
Acetylsalvipisone
Acetylsalvipisone is found in alcoholic beverages. Acetylsalvipisone is a constituent of Salvia sclarea (clary sage)
Propofol glucuronide
Propofol glucuronide is a metabolite of propofol. Propofol is a short-acting, intravenously administered hypnotic agent. Its uses include the induction and maintenance of general anesthesia, sedation for mechanically ventilated adults, and procedural sedation. Propofol is also commonly used in veterinary medicine. Propofol is approved for use in more than 50 countries, and generic versions are available. (Wikipedia)
1-dodecanoyl-glycero-3-phosphate
1-dodecanoyl-glycero-3-phosphate is also known as LPA(12:0/0:0) or (2R)-2-Hydroxy-3-(phosphonooxy)propyl laurate. 1-dodecanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-dodecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(i-12:0/0:0)
LysoPA(i-12:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-12:0/0:0), in particular, consists of one chain of isododecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
3-(4-(2-Dimethylamino-1-methylethoxy)phenyl)-1H-pyrazolo(3,4-b)pyridine-1-acetic acid
Pyroglutamyl-glutamyl-proline amide
4-Amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide
AZD7325 is a potent and orally active partial selective PAM of GABAAα2 and Aα3 receptor (Ki=0.3 and 1.3 nM, respectively), and has less antagonistic efficacy at the Aα1?and Aα5?receptor subtypes[1][4]. AZD7325 is a moderate?CYP1A2?and a potent?CYP3A4?inducer in vitro[2]. AZD7325 has the potential for the investigation of anxiety and dravet syndrome[3]. PAM: positive allosteric modulator.
Cellobioside
(4R,6S)-6-[(E)-2-[2-(4-Fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one
Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
Bronica
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents R - Respiratory system > R03 - Drugs for obstructive airway diseases D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].
Valganciclovir, (S)-
7-(2,5-Dihydroxy-3,4,6-trimethylphenyl)-7-phenylhept-6-enoic acid
URB937
URB937 is an orally active and peripherally restricted FAAH inhibitor (IC50=26.8 nM) and increases anandamide levels. URB937 fails to affect FAAH activity in the brain (not penetrate the blood-brain barrier)[1].
N-(3-Cyano-4,5-dimethyl-2-thienyl)-2-(4-phenylpiperazino)acetamide
3beta-acetoxyl-8beta,10beta-dihydroxy-6beta-methoxyeremophilenolide
6beta-acetoxy-7beta-hydroxy-1beta-methoxy-1alpha,8alpha-oxido-10beta,11betaH-eremophilan-12,8-olide
1-O-alpha-L-arabinofuranosyl-(1->6)-beta-D-galactopyranosyl isopropyl alcohol|pungen B
3alpha-propionyloxy-5beta-(4-hydroxytigloyloxy)-7-hydroxycarvotacetone|3alpha-propionyloxy-5beta-<4-hydroxytigloyloxy>-7-hydroxycarvotacetone
3-(alpha-Hydroxy-benzyl)-6-(alpha-methoxy-benzyl)-1-methyl-piperazin-2,5-dion|3-(alpha-hydroxy-benzyl)-6-(alpha-methoxy-benzyl)-1-methyl-piperazine-2,5-dione
4-O-beta-D-Glucopyranoside-4-Hydroxy-3-(3-methyl-2-butenyl)benzenemethanol
1-O-beta-Glucopyranoside-2-Methyl-6-(3-methyl-2-butenyl)-1,4-benzenediol,9CI
(1beta,5alpha,7beta,8beta)-8-(acetyloxy)-5-hydroperoxy-1-hydroxycostic acid methyl ester|methyl rel-(2R,3R,4aS,5R,8aR)-3-(acetyloxy)decahydro-8a-hydroperoxy-5-hydroxy-4a-methyl-a,8-bis(methylene)naphthalene-2-acetate
Isobutyric acid 2-methoxy-4-[3-(isobutyryloxy)-1,2-dihydroxypropyl]phenyl ester
(+)-welwitindolinone A|welwitindolinone A|welwitindolinone A isonitrile
Methyl 20-hydroxy-19-oxo-2,16-didehydrocuran-17-oate #
4alpha,10beta-dihydroxy-3alpha-methoxy-8alpha-acetoxy-11betaH-guai-1-en-12,6alpha-olide
2,3-Dimethoxy-7-methyl-9,10-methylenedioxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine-7-ium
Valganciclovir
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 2843
1,5-Bis-(2,4-dimethoxy-phenyl)-penta-1,4-dien-3-one
(E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
5,7-dihydroxy-2-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
1,8,10-trihydroxy-3-methoxy-6-methyl-10-(3-methylbut-2-enyl)anthracen-9-one
4-methoxy-6-[7-methoxy-3-methyl-5-[(E)-prop-1-enyl]-2,3-dihydro-1-benzofuran-2-yl]-1,3-benzodioxole
C21H22O5_4-[4,6-Dimethoxy-5-(3-methyl-2-buten-1-yl)-1-benzofuran-2-yl]-1,3-benzenediol
C14H26O10_Propyl 2-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
5,7-dihydroxy-2-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
Sultopride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Same as: D08549
(E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one [IIN-based: Match]
(E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one [IIN-based on: CCMSLIB00000846725]
2,2,4-Trimethylpentane-1,3-diyl dibenzoate
CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10463; ORIGINAL_PRECURSOR_SCAN_NO 10461 CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10565; ORIGINAL_PRECURSOR_SCAN_NO 10560 CONFIDENCE standard compound; INTERNAL_ID 1387; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10586; ORIGINAL_PRECURSOR_SCAN_NO 10581
Ala Ala Gly His
Ala Ala His Gly
Ala Gly Ala His
Ala Gly His Ala
Ala His Ala Gly
Ala His Gly Ala
Gly Ala Ala His
Gly Ala His Ala
Gly His Ala Ala
His Ala Ala Gly
His Ala Gly Ala
His Gly Ala Ala
Glyceollin IV
A member of the class of pterocarpans carrying two hydroxy substituents at positions 6a and 9 as well as prenyl and methoxy substituents at positions 2 and 3 respectively.
Xanthogalenol
A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 4, 2 and 6, a methoxy group at position 4 and a prenyl group at position 3.
Gancaonin I
A member of the class of 1-benzofurans which consists of 1-benzofuran substituted by methoxy groups at positions 4 and 6, a prenyl group at position 5 and a 2,4-dihydroxyphenyl group at position 2. It has been isolated from Glycyrrhiza uralensis.
Cymeval
2,3-Dihydro-7-methoxy-2-(3-methoxy-4,5-methylenedioxyphenyl)-3-methyl-5-(1-propenyl)benzofuran
Acetylsalvipisone
3'-Methoxyglabridin
Isopropyl apiosylglucoside
Boronic Acid, [1-(Triphenylmethyl)-1H-Pyrazol-4-YL
1,5-DIPHENYL-4-ETHYL-3-(4-METHOXYPHENYL)-1H-PYRAZOLE
6-[3-[[tert-butyl(dimethyl)silyl]oxymethyl]pyrrolidin-1-yl]-2-fluoropyridine-3-carboxylic acid
2-(4-Tert-Butylphenyl)-5-(4-Biphenyl)-1,3,4-Oxadiazole
Nomifensine
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.
N-(hydroxymethyl)prop-2-enamide,2-methylidenebutanoic acid,methyl 2-methylprop-2-enoate,prop-2-enenitrile
1-BENZYL-4-(4-NITRO-PHENYL)-PYRROLIDINE-3-CARBOXYLIC ACID ETHYL ESTER
Boc-5-Amino-6-chloropyridine-3-boronic acid pinacol ester
BENZYL 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YLCARBAMATE
N-(6-METHOXY-PYRIDIN-3-YL)-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZAMIDE
N-Benzyl-2-nitro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
1-octyl-2,3-dimethylimidazolium hexafluorophosphate
1,3-DIPHENYL-4-ETHYL-5-(4-METHOXYPHENYL)-1H-PYRAZOLE
Iclaprim
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01EA - Trimethoprim and derivatives C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists C254 - Anti-Infective Agent > C258 - Antibiotic
4,4-bis-(2,3-Epoxypropoxy)-3,3,5,5-tetramethylbiphenyl
1-hydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid
Tilnoprofen arbamel
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Benzyl (5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate
TERT-BUTYL 4-AMINOSPIRO[CHROMAN-2,4-PIPERIDINE]-1-CARBOXYLATE HYDROCHLORIDE
[Glu2]-TRH
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones (Glu2)-TRH, a metabolically stable analogue of Thyrotropin-releasing hormone (TRH; HY-P0002), is a negative modulator for the cholinergic effect of TRH in the mouse brain. (Glu2)-TRH significantly attenuates TRH-induced hippocampal extracellular acetylcholine release. (Glu2)-TRH is not metabolized by thyroliberinase. (Glu2)-TRH manifests neuroprotective, antidepressant, anticonvulsant in the CNS[1].
ETHYL 4-METHYL-2-(N-BOC-PIPERIDIN-4-YL)THIAZOL-5-YL CARBOXYLATE
BENZYL (5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)CARBAMATE
5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine
Nandrolone hydrogen sulfate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
abyssinone D
A chalcone having hydroxy substituents at positions 4, 2 and 4, a methoxy substituent at position 3 and a 3-methylbut-2-en-1-yl group at position 5. It is isolated from the stems of Erythrina abyssinica and displays moderate cytotoxic effect against human colorectal cancer cell line.
3-(3,5-Dimethyl-1-pyrazolyl)-6-[4-(4-fluorophenyl)-1-piperazinyl]-1,2,4,5-tetrazine
4-(9H-fluoren-9-yl)-N-(4-pyridinylmethylene)-1-piperazinamine
5-(4-fluorophenyl)-N-({5H,6H,7H,8H,9H-[1,2,4]triazolo[4,3-a]azepin-3-yl}methyl)furan-2-carboxamide
N-(trans-4-Nitro-4-stilbenyl)-N-methyl-5-amino-pentanoic acid
(1S)-1-Cyclopropyl-2-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrol-1-YL]-2-oxoethanamine
(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide
Seratrodast
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents R - Respiratory system > R03 - Drugs for obstructive airway diseases D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Seratrodast (AA 2414), an orally active antiasthmatic agent, is a thromboxane A2 receptor (TP) antagonist and ferroptosis inhibitor. Seratrodast reduces lipid ROS production, modulates the systemic xc-/GSH/GPX4 axis, and inhibits JNK phosphorylation and p53 expression. Seratrodast exhibits anti-asthmatic and anti-epileptic activity[1][2][3].
AIDS-096030
(6aS,11aS)-3-methoxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c][1]benzopyran-6a,9(11aH)-diol
2-((6-O-(beta-D-apiofuranosyl)beta-D-glucopyranosyl)oxy)propane
(1E,2E,4E)-1-[5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,6-dimethylocta-2,4-dien-1-olate
6-[(E)-2-[2-(4-fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one
7-(2,5-Dihydroxy-3,4,6-trimethylphenyl)-7-phenylhept-6-enoic acid
Ethyl (2S,3S)-3-[[(2S)-1-[[(2S)-1-hydroxypent-4-yn-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
(S)-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one
A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5 and 7, a methoxy group at position 4 and a prenyl group at position 8. It has been isolated from Macaranga bicolor.
7-Benzyl-1,3-dimethyl-8-piperazin-1-yl-3,7-dihydro-purine-2,6-dione
Tephrocandidin A
A monomethoxyflavanone that is (2S)-flavanone substituted by a methoxy group at position 5, a hydroxy group at position 7 and a 3-hydroxy-3-methylbut-1-en-1-yl group at position 8. It has been isolated from the aerial parts of Tephrosia candida.
N-[2-[oxo-(2-phenoxyethylamino)methyl]phenyl]-2-oxolanecarboxamide
1,8,10-Trihydroxy-3-methoxy-6-methyl-10-(3-methylbut-2-enyl)anthracen-9-one
5-[Diethylamino(oxo)methyl]-4-methyl-2-(1-oxopentylamino)-3-thiophenecarboxylic acid methyl ester
N-[3-[(2-phenyl-4-quinazolinyl)amino]phenyl]acetamide
N-hydroxy-N-[(E)-(4-pyridin-2-ylphenyl)methylideneamino]heptanediamide
N-hydroxy-N-[(E)-(4-pyridin-4-ylphenyl)methylideneamino]heptanediamide
N-hydroxy-N-[(E)-(4-pyridin-3-ylphenyl)methylideneamino]heptanediamide
2-[ethyl-[(4-oxo-1H-quinazolin-2-yl)methyl]amino]-N-(3-fluorophenyl)acetamide
1-(4-methoxyphenyl)-N-[2-(4-morpholinyl)ethyl]-4-pyrazolo[3,4-d]pyrimidinamine
N-[4-[(tert-butylamino)-oxomethyl]phenyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide
N-[2-[4-(dimethylamino)phenyl]-4-oxo-1,2-dihydroquinazolin-3-yl]carbamic acid ethyl ester
1-(2,4-Diphenyl-2,3-dihydro-1,5-benzodiazepin-1-yl)propan-1-one
2-O-methyl-alpha-L-fucopyranosyl-(1->2)-4-O-methyl-beta-D-galactopyranose
3,6-di-O-methyl-beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranose
A disaccharide derivative consisting of alpha-L-rhamnose having a 3,6-di-O-methyl-beta-D-glucosyl residue attached at the 4-position; corresponds to the carbohydrate portion of synthetic antigens containing the Mycobacterium leprae-specific epitope.
(2S)-5,7-dihydroxy-2-(4-methoxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
1-[(2R,3R)-1-[(2-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
1-[(2S,3R)-1-[(2-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
1-[(2S,3S)-1-[(2-fluorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
3-[2-(Hydroxymethyl)-5-methoxy-2-methylchromen-6-yl]-1-(4-hydroxyphenyl)propan-1-one
(1E,4E)-1,5-bis(2,4-dimethoxyphenyl)penta-1,4-dien-3-one
12-isothiocyanato-3-oxo-N-[(3S)-2-oxooxolan-3-yl]dodecanamide
4-methoxy-6-[7-methoxy-3-methyl-5-[(E)-prop-1-enyl]-2,3-dihydro-1-benzofuran-2-yl]-1,3-benzodioxole
methyl (2S)-2-[[2-[(4-methylbenzoyl)amino]benzoyl]amino]butanoate
Tert-butyldifluorotris(trimethylsilyl)methylsilane
1-Pentamethyldisilanyloxy-4-pentamethyldisilanylbenzene
(1S,12S,13S,14R,15E,17S)-15-ethylidene-7-methoxy-17-oxido-3-aza-17-azoniapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraene-13-carboxylic acid
1-lauroyl-sn-glycerol 3-phosphate
A 1-acyl-sn-glycerol 3-phosphate having lauroyl (dodecanoyl) as the 1-O-acyl group.
alpha-L-Fucp2Me-(1->2)-beta-D-Galp4Me
A disaccharide derivative consisting of a 2-O-methylfucosyl residue joined by an alpha-(1->2)-linkage to a 4-O-methyl-beta-D-galactose.
JZP-430
JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL)[1].
(3s)-3-hydroxy-1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)-3-phenylpropan-1-one
methyl (2r,3s,9s,10s,13s)-10-hydroxy-11-oxa-6,15-diazahexacyclo[12.7.0.0²,⁶.0³,¹⁰.0⁹,¹³.0¹⁶,²¹]henicosa-1(14),16,18,20-tetraene-13-carboxylate
(2s,3r,5s)-2-(2h-1,3-benzodioxol-5-ylmethyl)-5-methoxy-3-methyl-5-(prop-2-en-1-yl)-2,3-dihydro-1-benzofuran-6-one
(2s)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
14-methoxy-15-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene-5,10-diol
14-methoxy-10-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11(16),12,14-hexaene-5,13-diol
10-hydroxy-7-methoxy-3-[(2e,4r)-4-methylhex-2-en-2-yl]-1h-cyclohexa[g]isochromene-8,9-dione
4-[(6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl)oxy]furo[3,2-g]chromen-7-one
(3s)-7-hydroxy-3-[4-hydroxy-2-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-2,3-dihydro-1-benzopyran-4-one
(2r,3s)-2-(4-hydroxyphenyl)-5-methoxy-8,8-dimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol
5-methoxy-7-[2-(4-methoxyphenyl)-2-oxoethyl]-2,2-dimethyl-3h-1-benzopyran-4-one
3-{8,8-dimethyl-2h,3h,4h-pyrano[3,2-g]chromen-3-yl}-6-methoxybenzene-1,2-diol
(3r,4r,5r,7r)-5-chloro-4-ethenyl-4,8,8-trimethyl-3-(methylideneamino)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1,9(16),10,12,14-pentaen-15-ol
4-{[(2e,5r)-5-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}furo[3,2-g]chromen-7-one
(2s,4s)-5,7-dimethoxy-8-(3-methylbut-2-en-1-yl)-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-ol
3-(3,4-dihydroxy-2-methoxyphenyl)-1-[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
(2e)-1-(4-hydroxyphenyl)-3-[(2s)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-en-1-one
9-{[(2e)-5-[(2r)-3,3-dimethyloxiran-2-yl]-3-methylpent-2-en-1-yl]oxy}furo[3,2-g]chromen-7-one
8-(3,4-dimethoxyphenyl)-6,7-dimethyl-2h,6h,7h,8h-naphtho[2,3-d][1,3]dioxol-5-one
(11e)-17-hydroxy-3,5-dimethoxytricyclo[12.3.1.1²,⁶]nonadeca-1(18),2,5,11,14,16-hexaene-4,19-dione
5-methoxy-8,8-dimethyl-2-phenyl-2h,3h,4h-pyrano[2,3-f]chromene-3,4-diol
(1s)-3-(2,2-dimethylchromen-6-yl)-1-hydroxy-1-(4-hydroxy-2-methoxyphenyl)propan-2-one
(2r)-6-hydroxy-5-methoxy-7-[(3-methylbut-2-en-1-yl)oxy]-2-phenyl-2,3-dihydro-1-benzopyran-4-one
1-[2,6-dihydroxy-3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxyphenyl]-3-phenylprop-2-en-1-one
(1r,14s,18s,19r,22s)-22-hydroxy-8,10-dioxa-4,17-diazaheptacyclo[15.4.3.0¹,¹⁸.0⁴,¹⁹.0⁵,¹³.0⁷,¹¹.0¹⁴,¹⁹]tetracosa-5,7(11),12-trien-3-one
9-{[(2e,6r)-6-hydroxy-3,7-dimethylocta-2,7-dien-1-yl]oxy}furo[3,2-g]chromen-7-one
5-chloro-4-ethenyl-4,8,8-trimethyl-3-(methylideneamino)-14-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1,9(16),10,12,14-pentaen-15-ol
7-(3,7-dimethoxy-1,3-dihydro-2-benzofuran-1-yl)-3-hydroxy-3-methyl-2,4-dihydronaphthalen-1-one
(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methyl-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-isopropoxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol
(3r)-7-[(1r,3s)-3,7-dimethoxy-1,3-dihydro-2-benzofuran-1-yl]-3-hydroxy-3-methyl-2,4-dihydronaphthalen-1-one
(2e)-1-[(3s)-3,5-dihydroxy-7-methoxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]-3-phenylprop-2-en-1-one
(1s)-1-[4-(3,6-dioxocyclohexa-1,4-dien-1-yl)furan-3-yl]-4-methylpent-3-en-1-yl 3-methylbut-2-enoate
(2s)-2-hydroxy-3-(4-hydroxyphenyl)-1-(7-methoxy-2,2-dimethylchromen-6-yl)propan-1-one
(2e)-1-(2,4-dihydroxyphenyl)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]prop-2-en-1-one
(12r)-4,6-dimethoxy-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,8,10,15,18-octaene-5,12-diol
1-(ethylsulfanyl)-1-{[1-(ethylsulfanyl)hexyl]disulfanyl}hexane
(1r,5s,6s)-3-(hydroxymethyl)-6-isopropyl-2-oxo-5-(propanoyloxy)cyclohex-3-en-1-yl (2e)-4-hydroxy-2-methylbut-2-enoate
(2e)-1-[(4ar,8as)-5-hydroxy-7-methoxy-2,2-dimethyl-4a,8a-dihydrochromen-6-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
(2r)-2-{2-[3-(hydroxymethyl)-4-methoxy-2,6-dimethylphenyl]ethyl}-2-methylchromen-6-ol
1-(3,5-dihydroxy-7-methoxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl)-3-phenylprop-2-en-1-one
methyl (3as,4r,7ar)-4-{[(2s)-1-methoxy-1-oxopropan-2-yl]oxy}-3a,4,5,7a-tetrahydrospiro[1,3-benzodioxole-2,1'-cyclohexane]-6-carboxylate
2,8-dihydroxy-3,7-dimethyl-4,6-dipropylpyrido[3,2-g]quinoline-5,10-dione
4-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-2,3-dimethyl-3,4-dihydro-2h-naphthalen-1-one
1-(5-hydroxy-7-methoxy-2,2-dimethyl-4a,8a-dihydrochromen-6-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one
(1'r,2's,3s,7's,9'r)-6'-acetyl-2'-hydroxy-1-methyl-4'-oxa-12'-azaspiro[indole-3,10'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2-one
4-(6-hydroxy-3-methyl-1-benzofuran-2-yl)-5-methoxy-6-(3-methylbut-2-en-1-yl)benzene-1,3-diol
1-(7-hydroxy-6-isopropyl-2-methylnaphthalen-1-yl)-4-methyl-1-oxopent-3-en-2-yl acetate
16-hydroxyalstonal
{"Ingredient_id": "HBIN001911","Ingredient_name": "16-hydroxyalstonal","Alias": "NA","Ingredient_formula": "C20H22N2O4","Ingredient_Smile": "CC1=C(C2CC3C4(CC(C2(CO1)O)N3)C5=CC=CC=C5N(C4=O)C)C=O","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9775","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101730880","DrugBank_id": "NA"}
16-hydroxyalstonisine
{"Ingredient_id": "HBIN001912","Ingredient_name": "16-hydroxyalstonisine","Alias": "NA","Ingredient_formula": "C20H22N2O4","Ingredient_Smile": "CC(=O)C1=COCC2(C1CC3C4(CC2N3)C5=CC=CC=C5N(C4=O)C)O","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9776","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101730879","DrugBank_id": "NA"}
2S)-5,7-dihydroxy-4''-methoxy-8-prenylflavanone
{"Ingredient_id": "HBIN006761","Ingredient_name": "2S)-5,7-dihydroxy-4'\uff07-methoxy-8-prenylflavanone","Alias": "NA","Ingredient_formula": "C21H22O5","Ingredient_Smile": "CC(=CCC1=C(C=C(C2=C1OC(CC2=O)C3=CC=C(C=C3)OC)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41140","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3'-Hydroxy-4'-O-Methylglabridin
{"Ingredient_id": "HBIN008674","Ingredient_name": "3'-Hydroxy-4'-O-Methylglabridin","Alias": "NA","Ingredient_formula": "C21H22O5","Ingredient_Smile": "CC1(C=CC2=C(O1)C=CC3=C2OCC(C3)C4=C(C(=C(C=C4)OC)O)O)C","Ingredient_weight": "354.4 g/mol","OB_score": "43.71495141","CAS_id": "NA","SymMap_id": "SMIT06795","TCMID_id": "NA","TCMSP_id": "MOL004966","TCM_ID_id": "NA","PubChem_id": "15228662","DrugBank_id": "NA"}
5-deoxyabyssinin ii
{"Ingredient_id": "HBIN011513","Ingredient_name": "5-deoxyabyssinin ii","Alias": "NA","Ingredient_formula": "C21H22O5","Ingredient_Smile": "CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(O2)C=C(C=C3)O)OC)O)C","Ingredient_weight": "354.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5145","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44424649","DrugBank_id": "NA"}
8-[(3,7-dimethyl-2,6-octadienyl)oxy]-7h-furo[3,2-g][1]benzopyran-7-one,9ci; 6',7'-dihydro,6'-oxo
{"Ingredient_id": "HBIN013564","Ingredient_name": "8-[(3,7-dimethyl-2,6-octadienyl)oxy]-7h-furo[3,2-g][1]benzopyran-7-one,9ci; 6',7'-dihydro,6'-oxo","Alias": "NA","Ingredient_formula": "C21H22O5","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7389","PubChem_id": "NA","DrugBank_id": "NA"}
8-(3,7-dimethyl-6-oxo-2-octenyloxy)psoralen
{"Ingredient_id": "HBIN013565","Ingredient_name": "8-(3,7-dimethyl-6-oxo-2-octenyloxy)psoralen","Alias": "NA","Ingredient_formula": "C21H22O5","Ingredient_Smile": "NA","Ingredient_weight": "354.402","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7413","PubChem_id": "NA","DrugBank_id": "NA"}